This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ransom, J. H. Articles by Hanna, M. G. Search for Related Content PubMed PubMed Citation Articles by Ransom, J. H. Articles by Hanna, M. G., Jr.

Expression of Class II Major Histocompatibility Complex Molecules Correlates with Human Colon Tumor Vaccine Efficacy

Organon Teknika, Biotechnology Research Institute, Rockville, Maryland 20850

Vaccination of colon cancer patients with X-irradiated autologous tumor cells and Bacillus Calmette-Guérin results in a significant reduction in tumor recurrence. A study was undertaken to determine whether the expression of tumor-associated antigens, expression of major histocompatibility complex molecules, or the cellular composition of the vaccine cells correlates with vaccine efficacy. A significant increase in the percentage of histocompatibility leukocyte antigen (HLA) class II molecule-expressing tumor cells was the only marker with a positive correlation. Because HLA class II molecule expression is not a prognostic marker in control patients, it was hypothesized that HLA class II molecules are involved in the induction of tumor immunity in patients treated with the autologous colon tumor vaccine. Enhancement of HLA class II molecule-expressing cells could be induced in X-irradiated colon tumor cells injected into the skin of mice when the cells were mixed with -interferon. Therefore, addition of -interferon to the colon tumor vaccine, resulting in increased numbers of HLA class II molecule-expressing cells, could potentiate the generation of tumor immunity.

¹ To whom requests for reprints should be addressed, at Organon Teknika/Biotechnology Research Institute, 1330-A Piccard Drive, Rockville, MD 20850.

Received 9/ 3/91. Accepted 3/30/92.

This article has been cited by other articles:

				C. Maccalli, Y. F. Li, M. El-Gamil, S. A. Rosenberg, and P. F. Robbins Identification of a Colorectal Tumor-Associated Antigen (COA-1) Recognized by CD4+ T Lymphocytes Cancer Res., October 15, 2003; 63(20): 6735 - 6743. [Abstract] [Full Text] [PDF]